The annual report says the SOB had been a director since 2/2000 and became ceo in 11/2000. BTW he was the one who bought the Critical Care System that cost the company $165M. That loan is one of the major problems we have here.
I bought the major part of my shares after I saw the newly hired COO, Paul McConnell, bought lots of share on the open market. Later I found that the SOB Fishhead had arranged for CURE to loan over $1M to paul to purchase those shares on the open market to make it appear as an insider buy. The fact that Paul was required to buy those shares as part of his employment contract was only in the small prints of their SEC filings and pretty much hidden to the average buyer. Live and learn!